Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Operating Leases (2022 - 2025)

Cellebrite DI has reported Operating Leases over the past 4 years, most recently at $18.7 million for Q4 2025.

  • Quarterly results put Operating Leases at $18.7 million for Q4 2025, up 172.85% from a year ago — trailing twelve months through Dec 2025 was $18.7 million (up 172.85% YoY), and the annual figure for FY2025 was $18.7 million, up 172.85%.
  • Operating Leases for Q4 2025 was $18.7 million at Cellebrite DI, up from $6.8 million in the prior quarter.
  • Over the last five years, Operating Leases for CLBT hit a ceiling of $18.7 million in Q4 2025 and a floor of $6.8 million in Q4 2024.
  • Median Operating Leases over the past 4 years was $9.8 million (2022), compared with a mean of $11.3 million.
  • Biggest five-year swings in Operating Leases: decreased 25.26% in 2024 and later soared 172.85% in 2025.
  • Cellebrite DI's Operating Leases stood at $10.4 million in 2022, then decreased by 11.55% to $9.2 million in 2023, then decreased by 25.26% to $6.8 million in 2024, then soared by 172.85% to $18.7 million in 2025.
  • The last three reported values for Operating Leases were $18.7 million (Q4 2025), $6.8 million (Q4 2024), and $9.2 million (Q4 2023) per Business Quant data.